Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 36 results found. Search for [ nasal vaccine ]

Results 1 to 21 of 36
PTI
November 16, 2020
Speaking virtually at a programme organised by the Indian School of Business, Ella said the company is also working on another vaccine for COVID-19 which would be in the form of nasal drops and can be ready by next year


BusinessToday.In
November 16, 2020
The scientists found that the mutated virus not only replicates about 10 times faster but it was also much more infectious


Chitranjan Kumar
November 7, 2020
As per the terms of the proposed agreement, Goldman Sachs will be issued optionally convertible debentures at a post money equity valuation of $ 3.94 billion


BusinessToday.In
November 7, 2020
India may concentrate its efforts on Bharat Biotech's Covaxin as AstraZeneca's COVID-19 vaccine deliveries may be delayed. The months of November and December could be critical in terms of vaccine availability as a number of companies are likely to publish late-stage trial data


BusinessToday.In
November 4, 2020
Scientists have developed a vaccine candidate for COVID-19 that produces high levels of antibodies and better immune response in animals. J&J vaccine trials have resumed in Brazil and Mexico has received coronavirus vaccine from CanSino Biologics for late-stage trials


PTI
November 1, 2020
Bharat Biotech Executive Director Sai Prasad said the price of the vaccine is yet to be determined, as the company is still looking at the cost of product development


BusinessToday.In
October 30, 2020
The company said that it has been listed ahead of global pharma companies such as Roche, Eli Lilly, Abbott, Novartis, and Pfizer in this year's rankings


BusinessToday.In
October 28, 2020
A non-peer-reviewed study of over 84,000 people, led by Adam Hampshire, a doctor at Imperial College London, discovered that in some cases, coronavirus infection is associated with substantial cognitive deficits for months


PB Jayakumar & Joe C Mathew
October 26, 2020
Zydus Cadila's COVID-19 candidate vaccine ZyCov-D, which is currently undergoing second phase of clinical trials in India, is likely to enter Phase III final stage of clinical trials by December 2020


BusinessToday.In
October 26, 2020
Sharing a BusinessToday.In report stating that the new nasal vaccine can be a game-changer for COVID-19 testing, Shaw tweeted that these inoculations will be far easier to deliver than intra muscular injections


BusinessToday.In
October 26, 2020
The outcome of immunogenicity blood tests conducted on a subgroup of older study participants echoed data published in July this year that revealed that the coronavirus vaccine produced robust immune responses in healthy adults aged 18-55 years


BusinessToday.In
October 26, 2020
Coronavirus vaccine: The pharma company plans to start late-stage trials of the vaccine candidate next month. Over 26,000 candidates would be monitored for the vaccine candidate's efficacy


PTI
October 25, 2020
Seventy-five per cent of the new recoveries were observed to be concentrated in 10 states and Union territories -- Maharashtra, Karnataka, Kerala, Tamil Nadu, West Bengal, Delhi, Andhra Pradesh, Assam, Uttar Pradesh and Chhattisgarh


PB Jayakumar | Joe C Mathew
October 25, 2020
Coronavirus vaccine administered through the intramuscular injection route protects the lower lungs but not the upper lung. Nasal vaccines can protect the lungs completely and stop transmission and also infection


BusinessToday.In
October 22, 2020
Bharat Biotech Phase 3 trials: The volunteers would be given two doses of the experimental vaccine in a gap of 28 days


BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 19, 2020
Chebrolu's invention is based on in-silico methodology. In this, a lead molecule selectively binds with spike protein of COVID-19. She is now planning to work with scientists who are working tirelessly to find vaccine against COVID-19


Joe C Mathew
October 18, 2020
Coronavirus vaccine: While there are no intranasal COVID-19 vaccines under trial in India at the moment, the two companies will pursue clinical trials of such vaccines in India in the coming months


BusinessToday.In
October 9, 2020
Bharat Biotech vaccine: The subject expert committee that discussed the matter in a meeting on October 5 has asked the company to resubmit the protocol and clarify the definition of asymptomatic


BusinessToday.In
October 2, 2020
In a research paper published in the journal PAIN, the scientists raised the possibility that pain, as an early symptom of COVID-19, may be reduced by the coronavirus spike protein as it silences the \"body's pain signaling pathways\"


PAGES 1 OF 2  12